Brainsway Deep TMS for Major Depressive Disorder

FAQ for Physicians - Major Depressive Disorder Treatment

Get all the information relevant for providing your major depressive disorder patients with Brainsway Deep TMS. 

Brainsway® Deep TMS treatment has been proven safe and effective*, and has no known systemic side effects*. The most common side effect is temporary, mild pain or discomfort in the area of the treatment site, which occurs during the treatment session. This typically occurs only during the first week of TMS treatment. Other side effects may include muscle twitching and jaw pain*.

For references relating to this issue click here

 

 

 

While ECT entails electrically induced seizures, Brainsway* Deep TMS therapy stimulates brain regions using brief magnetic pulses at an amplitude similar to that used in MRI systems. ECT requires anesthesia and may entail severe side effects, including memory loss, while Deep TMS therapy does not involve anesthesia, has no effects on memory, and is generally well-tolerated*. 

* For references relating to this issue click here

 

 

Brainsway* Deep TMS is effective* for a wide range of depression patients, including severe, treatment resistant depression cases. The FDA* has cleared Brainsway Deep TMS therapy for treating patients with depression, who tried 1-4 of antidepressants with no improvement. 

* For references relating to this issue click here

Typically, patients hear a tapping sound and feel a tapping sensation in the head area during the TMS therapy session. To diminish the sound, the patient is provided with earplugs.

Some patients experience temporary, mild pain or discomfort in the area of the treatment site, which occurs during the treatment session. This typically occurs only during the first week of TMS treatment. Other side effects may include muscle twitching and jaw pain*. 

 For more information about Brainsway* Deep TMS therapy, please contact the Deep TMS Center at 1855-200-dTMS.

* For references relating to this issue click here

In general, our TMS therapy should not be used for patients with metal implants in or around the head (except for standard amalgam dental fillings). Please consult the Deep TMS Center at 1855-200-dTMS to verify whether your patient is eligible for Brainsway* Deep TMS therapy.

Brainsway* Deep TMS therapy has been tested in over 60 clinical studies, for various clinical indications, in leading institutions worldwide. The FDA* has cleared this TMS therapy for treatment resistant depression and it is currently available in the U.S., Europe, and South America. 

* For references relating to this issue click here


© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use